PAQR7 and acute myeloid leukemia: Variables independently associated with MRPA-BSI were AML (OR = 19.5, 95% CI 2.03–187, p-value = 0.01) and prior use of amikacin (OR = 0.06, 95% CI 0.006–0.581, p-value = 0.015) when Non-GN controls were used.